Britt Erickson

ORCID: 0000-0001-5221-5538 · 10 papers in corpus
2026
Cancer medicine ·doi:10.1002/cam4.72003

BackgroundMost ovarian cancers are detected at advanced stages, with poor outcomes. Ovarian cancer is heterogeneous; the most common subtype, serous ovarian carcinoma, may originate outside of the ovaries. To inform etiologic heterogeneity,…

2025
American Journal of Epidemiology ·doi:10.1093/aje/kwae293

Ovarian cancer is a rare and highly heterogeneous disease usually detected at late stages when outcomes are poor. Population-based screening approaches have not been successful at reducing ovarian cancer mortality, but preventive bilateral …

2025
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-25-1878

PurposeTo evaluate exemestane, an aromatase inhibitor, as a preventive intervention for endometrial cancer.Experimental designThis is a multicenter, single-arm, "window of opportunity" pilot study of exemestane (25 mg daily for 21-42 days) …

2022
Cancer research communications ·doi:10.1158/2767-9764.crc-22-0122

Targeting glutamine metabolism has emerged as a novel therapeutic strategy for several human cancers, including ovarian cancer. The primary target of this approach is the kidney isoform of glutaminase, glutaminase 1 (GLS1), a key enzyme in …

2019
Obstetrics and gynecology ·doi:10.1097/aog.0000000000003421

ObjectiveTo evaluate health care provider adherence to the surgical protocol endorsed by the National Comprehensive Cancer Network and the American College of Obstetricians and Gynecologists at the time of risk-reducing salpingo-oophorectom…

2019
Gynecologic oncology reports ·doi:10.1016/j.gore.2019.100503

Primary vaginal leiomyosarcoma (LMS) is a rare entity with limited data on optimal treatment approach. Most previously reported cases utilize an open or transvaginal surgical approach for primary tumor resection. Minimally invasive surgery …

article 2018
Gynecologic oncology reports ·doi:10.1016/j.gore.2018.06.009

•Mullerian Carcinosarcoma (MC) is one of the rarest endometriosis associated malignancies (EAM).•Atypical endometriosis can undergo variety of metaplastic changes causing diagnostic dilemma.•Atypical endometriosis possibly represents a prec…

2017
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.12.004

ObjectivesTo determine if 6 versus 3cycles of adjuvant platinum-based chemotherapy with or without taxane impacts survival in early stage ovarian clear cell carcinoma (OCCC).MethodsWe retrospectively identified all cases of stage I and II O…

2016
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0000000000000559

ObjectiveThe purpose of this study was to assess the rate of lymph node (LN) metastasis in comprehensively staged ovarian clear cell carcinoma (OCCC) clinically confined to the ovary and determine factors associated with LN metastasis.Metho…

2013
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2013.04.019

Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies have a relatively poor prognosis and collectively remain the most deadly of all gynecologic malignancies. Although traditionally thought of as one dise…